Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis

Objectives: Pneumocystis jirovecii pneumonia (PCP) is an AIDS-defining illness. In patients with HIV, the benefit of PCP prophylaxis is well-defined when the CD4 T-cell count decreases below 200 cells/μL. In other immunocompromised patients, the value of PCP prophylaxis is not always as well-establi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Cell Infect Microbiol
Autori principali: Dunbar, Albert, Schauwvlieghe, Alexander, Algoe, Sheruna, van Hellemond, Jaap J., Reynders, Marijke, Vandecasteele, Stefaan, Boelens, Jerina, Depuydt, Pieter, Rijnders, Bart
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Cellular and Infection Microbiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243458/
https://ncbi.nlm.nih.gov/pubmed/32500040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2020.00224
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi